苏黎世杏仁核-海马切除术系列：简短更新

The Zürich amygdalo-hippocampectomy series: a short up-date.

作者信息

Wieser H G, Siegel A M, Yaşargil G M

机构信息

Neurological Department, University Hospital Zürich, Switzerland.

出版信息

Acta Neurochir Suppl (Wien). 1990;50:122-7. doi: 10.1007/978-3-7091-9104-0_24.

DOI:10.1007/978-3-7091-9104-0_24

PMID:2097887

Abstract

Selective amygdalohippocampectomy was developed as a surgical treatment for temporal lobe epilesy with a well-defined unilateral mesiobasal limbic seizure onset. Since 1975, 236 patients have been operated on in Zürich. We briefly summarize recent studies on the seizure outcome with analysis of the postoperative long-term fluctuations in relation to postoperative anticonvulsant drug treatment, on the underlying neuropathology, and on the relationships between magnetic resonance scanning estimates of total volume of the removed tissue and the resection scores of amygdala, hippocampus and parahippocampus gyrus.

摘要

选择性杏仁核海马切除术是作为一种针对颞叶癫痫的外科治疗方法而开发的，其具有明确的单侧内侧基底边缘性癫痫发作起始点。自1975年以来，苏黎世已有236例患者接受了该手术。我们简要总结了近期关于癫痫发作结果的研究，分析了与术后抗惊厥药物治疗相关的术后长期波动情况、潜在的神经病理学，以及切除组织总体积的磁共振扫描估计值与杏仁核、海马体和海马旁回切除评分之间的关系。